Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
READY 1
2019-002124-32Phase 3Completed
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Start
- Dec 2019
- Modality
- Metabolic Enzymes → Therapeutic Enzymes → Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of CUSA-081 in catheter-related thrombosis (CRT) (3 arms), sponsored by Chiesi Farmaceutici S.p.A. Started Dec 2019; status: completed.
02
Drugs
CUSA-081
03
Conditions
catheter-related thrombosis (CRT)
Beyond the preview
Go deeper on 2019-002124-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-002124-32.